Literature DB >> 20619712

Apollo contributes to G overhang maintenance and protects leading-end telomeres.

Peng Wu1, Megan van Overbeek, Sean Rooney, Titia de Lange.   

Abstract

Mammalian telomeres contain a single-stranded 3' overhang that is thought to mediate telomere protection. Here we identify the TRF2-interacting factor Apollo as a nuclease that contributes to the generation/maintenance of this overhang. The function of mouse Apollo was determined using Cre-mediated gene deletion, complementation with Apollo mutants, and the TRF2-F120A mutant that cannot bind Apollo. Cells lacking Apollo activated the ATM kinase at their telomeres in S phase and showed leading-end telomere fusions. These telomere dysfunction phenotypes were accompanied by a reduction in the telomeric overhang signal. The telomeric functions of Apollo required its TRF2-interaction and nuclease motifs. Thus, TRF2 recruits the Apollo nuclease to process telomere ends synthesized by leading-strand DNA synthesis, thereby creating a terminal structure that avoids ATM activation and resists end-joining. These data establish that the telomeric overhang is required for the protection of telomeres from the DNA damage response. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619712      PMCID: PMC2929323          DOI: 10.1016/j.molcel.2010.06.031

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  48 in total

1.  DNA damage foci at dysfunctional telomeres.

Authors:  Hiroyuki Takai; Agata Smogorzewska; Titia de Lange
Journal:  Curr Biol       Date:  2003-09-02       Impact factor: 10.834

2.  Functional and biochemical dissection of the structure-specific nuclease ARTEMIS.

Authors:  Ulrich Pannicke; Yunmei Ma; Karl-Peter Hopfner; Doris Niewolik; Michael R Lieber; Klaus Schwarz
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

3.  TRF2 protects human telomeres from end-to-end fusions.

Authors:  B van Steensel; A Smogorzewska; T de Lange
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

4.  Normal human chromosomes have long G-rich telomeric overhangs at one end.

Authors:  W E Wright; V M Tesmer; K E Huffman; S D Levene; J W Shay
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

5.  The terminal DNA structure of mammalian chromosomes.

Authors:  R McElligott; R J Wellinger
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening.

Authors:  V L Makarov; Y Hirose; J P Langmore
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

7.  G-strand overhangs on telomeres in telomerase-deficient mouse cells.

Authors:  M T Hemann; C W Greider
Journal:  Nucleic Acids Res       Date:  1999-10-15       Impact factor: 16.971

8.  The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

9.  Mammalian telomeres end in a large duplex loop.

Authors:  J D Griffith; L Comeau; S Rosenfield; R M Stansel; A Bianchi; H Moss; T de Lange
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

10.  Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation.

Authors:  Ilja Demuth; Martin Digweed; Patrick Concannon
Journal:  Oncogene       Date:  2004-11-11       Impact factor: 9.867

View more
  78 in total

1.  Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening.

Authors:  Tracy T Chow; Yong Zhao; Sabrina S Mak; Jerry W Shay; Woodring E Wright
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Telomere end processing: unexpected complexity at the end game.

Authors:  Victoria Lundblad
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  For cancers there is more to life than a longer G-strand.

Authors:  Jeremy D Henson
Journal:  Asian J Androl       Date:  2010-09-13       Impact factor: 3.285

4.  The SNM1B/APOLLO DNA nuclease functions in resolution of replication stress and maintenance of common fragile site stability.

Authors:  Jennifer M Mason; Ishita Das; Martin Arlt; Neil Patel; Stephanie Kraftson; Thomas W Glover; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2013-07-17       Impact factor: 6.150

Review 5.  How will telomeric complex be further contributed to our longevity? - the potential novel biomarkers of telomere complex counteracting both aging and cancer.

Authors:  Yiming Lu; Bohua Wei; Tao Zhang; Zi Chen; Jing Ye
Journal:  Protein Cell       Date:  2013-07-18       Impact factor: 14.870

Review 6.  Stop pulling my strings - what telomeres taught us about the DNA damage response.

Authors:  Eros Lazzerini-Denchi; Agnel Sfeir
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-11       Impact factor: 94.444

7.  Telomere-end processing: mechanisms and regulation.

Authors:  Diego Bonetti; Marina Martina; Marco Falcettoni; Maria Pia Longhese
Journal:  Chromosoma       Date:  2013-10-12       Impact factor: 4.316

8.  Involvement of telomerase reverse transcriptase in heterochromatin maintenance.

Authors:  Yoshiko Maida; Mami Yasukawa; Naoko Okamoto; Seii Ohka; Keita Kinoshita; Yasushi Totoki; Takashi K Ito; Tohru Minamino; Hiromi Nakamura; Satoko Yamaguchi; Tatsuhiro Shibata; Kenkichi Masutomi
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

9.  Tying up the Ends: Plasticity in the Recognition of Single-Stranded DNA at Telomeres.

Authors:  Neil R Lloyd; Thayne H Dickey; Robert A Hom; Deborah S Wuttke
Journal:  Biochemistry       Date:  2016-09-15       Impact factor: 3.162

10.  A sequence-dependent exonuclease activity from Tetrahymena thermophila.

Authors:  Hui-I Kao Tom; Carol W Greider
Journal:  BMC Biochem       Date:  2010-11-16       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.